Skip to main content

Table 3 Absolute and relative educational inequalities in site-specific cancer mortality among Belgian men aged 50–79 years for the period 2001–2008

From: Evolution of educational inequalities in site-specific cancer mortality among Belgian men between the 1990s and 2000s using a “fundamental cause” perspective

Cancer site   Total population Low educated c Mid educated d High educated e MRD f,g (95% CI h)
Total cancer mortality ASMR a 687.0 (682.0–692.1) 729.8 (722.8–736.8) 612.6 (600.5–624.6) 491.4 (480.1–502.7) 238.4 (234.1–242.7)
MRR b   1.55 (1.52–1.59) 1.29 (1.25–1.33) 1.00  
Head and neck ASMR 30.7 (29.6–31.7) 33.4 (31.8–34.9) 26.4 (24.0–28.8) 18.7 (16.6–20.7) 14.7 (14.2–15.2)
MRR   1.95 (1.74–2.19) 1.50 (1.31–1.72) 1.00  
Oesophagus ASMR 24.6 (23.6–25.5) 24.9 (23.6–26.2) 25.1 (22.7–27.5) 21.4 (19.1–23.7) 3.5 (2.5–4.5)
MRR   1.26 (1.12–1.42) 1.24 (1.08–1.43) 1.00  
Stomach ASMR 22.0 (21.1–22.9) 23.8 (22.5–25.0) 17.2 (15.1–19.2) 16.1 (14.0–18.1) 7.7 (6.9–8.5)
MRR   1.50 (1.31–1.72) 1.09 (0.92–1.29) 1.00  
Colorectal ASMR 65.9 (64.3–67.4) 66.2 (64.1–68.3) 63.2 (59.3–67.1) 52.4 (50.4–58.0) 13.8 (10.3–13.7)
MRR   1.25 (1.16–1.34) 1.19 (1.09–1.30) 1.00  
Liver ASMR 19.5 (18.6–20.3) 18.8 (17.7–20.0) 20.7 (18.5–22.9) 18.9 (16.7–21.2) −0.1 (−1.2–1.0)
MRR   1.10 (0.96–1.25) 1.20 (1.03–1.41) 1.00  
Pancreas ASMR 33.2 (32.0–34.3) 33.8 (32.3–35.3) 31.3 (28.5–34.0) 33.5 (30.5–36.5) 0.3 (−1.2–1.8)
MRR   1.07 (0.97–1.18) 0.98 (0.87–1.11) 1.00  
Lung and trachea ASMR 252.9 (249.9–256.0) 286.1 (281.7–290.5) 196.7 (189.9–203.6) 134.4 (128.5–140.3) 151.7 (150.2–153.2)
MRR   2.23 (2.13–2.33) 1.52 (1.44–1.60) 1.00  
Melanoma ASMR 6.0 (5.5–6.5) 5.8 (5.2–6.4) 7.0 (5.8–8.3) 6.4 (5.2–7.7) −0.6 (−1.3–0.0)
MRR   0.89 (0.72–1.11) 1.05 (0.81–1.35) 1.00  
Prostate ASMR 48.4 (47.0–49.7) 47.7 (45.9–49.4) 46.7 (43.2–50.2) 43.7 (40.2–47.3) 4.0 (2.1–5.7)
MRR   1.11 (1.02–1.21) 1.06 (0.95–1.18) 1.00  
Kidney ASMR 18.9 (18.0–19.7) 19.1 (18.0–20.2) 20.1 (17.8–22.3) 16.8 (14.7–18.9) 2.3 (1.3–3.3)
MRR   1.15 (1.00–1.31) 1.17 (0.99–1.37) 1.00  
Bladder ASMR 24.8 (23.8–25.8) 25.3 (24.0–26.6) 23.3 (20.8–25.7) 17.8 (15.6–20.0) 7.5 (6.6–8.4)
MRR   1.49 (1.30–1.70) 1.34 (1.14–1.57) 1.00  
Eye, brain, central nervous system ASMR 14.9 (14.2–15.7) 14.9 (13.9–15.9) 14.8 (13.0–16.7) 14.1 (12.3–15.9) 0.8 (0.0–1.6)
MRR   1.06 (0.92–1.22) 1.04 (0.88–1.24) 1.00  
Non-Hodgkin Lymphoma ASMR 14.4 (13.7–15.1) 13.9 (13.0–14.9) 15.9 (13.9–17.9) 13.2 (11.3–15.1) 0.7 (−0.2–1.7)
MRR   1.09 (0.93–1.27) 1.23 (1.02–1.47) 1.00  
Multiple myeloma ASMR 9.8 (9.2–10.4) 9.9 (9.1–10.7) 10.8 (9.2–12.5) 8.6 (7.1–10.1) 1.3 (0.6–2.0)
MRR   1.12 (0.93–1.35) 1.20 (0.96–1.51) 1.00  
Leukaemia ASMR 18.9 (18.1–19.8) 18.8 (17.7–19.9) 19.1 (16.9–21.3) 17.2 (15.0–19.4) 1.6 (0.5–2.7)
MRR   1.14 (0.99–1.31) 1.12 (0.95–1.33) 1.00  
  1. aAge-standardized mortality rate using the Belgian population at the moment of the 2001 census as reference; expressed per 100,000 men
  2. bMortality Rate Ratio
  3. cLow-educated persons have completed lower secondary education or less
  4. dMid-educated persons have completed upper secondary education
  5. eHigh-education persons have completed tertiary education
  6. fMortality rate difference
  7. gThe difference between the ASMR of the lowest educated and the ASMR of the highest educated
  8. h95% Confidence Intervals